Viewing Study NCT03063203


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-12 @ 11:04 PM
Study NCT ID: NCT03063203
Status: TERMINATED
Last Update Posted: 2022-06-02
First Post: 2017-02-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Washington University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Acute Myeloid Leukemia, Relapsed, Adult View
Keywords: